drug protocol number

D8220R0008

drug sponsor

Astrazeneca

drug study

Acalabrutinib

drug trial site

King Khalid University Hospital (Riyadh), King Abdulaziz Medical City NG (Riyadh), King Abdulaziz Medical City NG (Jeddah), King Fahad Specialist Hospital (Dammam)

drug status

Ongoing

drug phase